Big Gain For Vaxart, Inc.
Thu, Feb 27, 2020 at 05:30 PM
Vaxart, Inc. (VXRT:NASDAQ) jumped higher at $2.47, a gain of 49.7%. On Wed 26 Feb 20, VXRT:NASDAQ touched a New 2-Week High of $1.65. The stock got featured on our News Catalysts scanner on Wed 26 Feb 20 at 07:54 PM in the 'MISCELLANEOUS' category. From Wed 05 Feb 20, the stock recorded 50.00% Up Days and 46.67% Green Days
About Vaxart, Inc. (VXRT:NASDAQ)
Aviragen Therapeutics Inc is a bio-pharmaceutical company. It is engaged in developing direct-acting antivirals to treat infections that affect a number of patients. It includes oral, small molecule compounds to treat infectious diseases.
Top 10 Gainers:
- Allied Healthcare Products, Inc. (AHPI:NASDAQ), 321.74%
- iBio, Inc. (IBIO:NYSEMKT), 158.98%
- Alpha Pro Tech, Ltd. (APT:NYSEMKT), 103.79%
- Tonix Pharmaceuticals Holding Corp. (TNXP:NASDAQ), 92.22%
- Co-Diagnostics, Inc. (CODX:NASDAQ), 79.33%
- Vir Biotechnology, Inc. (VIR:NASDAQ), 72.12%
- GAIN Capital Holdings, Inc. (GCAP:NYSE), 66.01%
- Aethlon Medical, Inc. (AEMD:NASDAQ), 58.73%
- Guardion Health Sciences, Inc. (GHSI:NASDAQ), 54.05%
- Vaxart, Inc. (VXRT:NASDAQ), 49.7%